ACCOUNT

SECTIONS

HOME
- Homepage
- This Just In
- Chats
- Weather
- Traffic
- Event Guide
- PG Store
- PGe
- Video
- Photos
- The Digs
- RSS Feeds
NEWS
- News Home
- COVID-19
- World
- Nation
- State
- Obituaries
- News Obituaries
- Politics
- Education
- Portfolio
- Science
- Health & Wellness
- Environment
- Aging Edge
- Transportation
- Faith & Religion
- Crimes & Courts
- Social Services
LOCAL
- Local Home
- Region
- City
- North
- East
- West
- South
- Washington
- Westmoreland
- The Neighborhood
- Obituaries
- Classifieds
- Legal Notices
- Real Estate
SPORTS
- Sports Home
- Steelers
- Penguins
- Pirates
- Sports Columns
- Gene Collier
- Ron Cook
- Joe Starkey
- Paul Zeise
- High School Sports
- College Sports
- Pitt
- Penn State
- WVU
- NCAA
- NFL
- MLB
- NBA
- NHL
- North Shore Drive Podcast
OPINION
A&E
- A&E Home
- Celebrities
- Movies
- TV & Radio
- Music
- Concert Listings
- Theatre & Dance
- Art & Architecture
- Books
- Events
LIFE
- Life Home
- Food
- Buying Here
- Homes & Gardens
- Style & Fashion
- Travel
- Restaurants
- Seen
- goodness
- Random Acts of Kindness
- Pets
- Beer Me
- Outdoors
- Holidays
BUSINESS

OTHER

CLASSIFIEDS

Recent Quotes

My Watchlist

Indicators

Markets:

Overview

News

Currencies

International

Treasuries

Compass Therapeutics, Inc. - Common Stock (NQ:CMPX)

5.360 -0.020 (-0.37%)

Streaming Delayed Price Updated: 11:13 AM EST, Dec 31, 2025 Add to My Watchlist

Price and Volume

Detailed Quote

Volume	386,772
Open	5.370
Bid (Size)	5.360 (500)
Ask (Size)	5.370 (1,900)
Prev. Close	5.380
Today's Range	5.190 - 5.410
52wk Range	1.330 - 5.860
Shares Outstanding	127,486,326
Dividend Yield	N/A

Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News

Compass Therapeutics Inc (NASDAQ:CMPX) Reports Wider Q2 2025 Loss, Shares Show Mixed Reaction Amid Clinical Progress ↗

August 11, 2025

Compass Therapeutics reports Q2 2025 results with a wider-than-expected loss but shows progress in clinical trials for oncology treatments. Market reacts mixedly.

Via Chartmill

Compass Therapeutics Posts Wider Q2 Loss ↗

August 11, 2025

Via The Motley Fool

Performance

YTD	+282.9%	+282.9%
1 Month	-2.0%	-2.0%
3 Month	+53.1%	+53.1%
6 Month	+107.8%	+107.8%
1 Year	+262.2%	+262.2%

More News

Top movers in Wednesday's session ↗

April 02, 2025

Via Chartmill

Small Cap Compass Therapeutics Shares Positive Primary Goal Data From Pivotal Cancer Drug Study For Biliary Tract Cancer ↗

April 01, 2025

Via Benzinga

Recap: Compass Therapeutics Q3 Earnings ↗

November 09, 2023

Via Benzinga

Earnings Scheduled For August 11, 2025 ↗

August 11, 2025

Via Benzinga

What's going on in today's after hours session ↗

March 31, 2025

Via Chartmill

12 Health Care Stocks Moving In Monday's After-Market Session ↗

March 31, 2025

Via Benzinga

This Smithfield Foods Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Monday ↗

February 24, 2025

Via Benzinga

This GE Vernova Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Wednesday ↗

February 19, 2025

Via Benzinga

Top 3 High-Momentum Companies Analysts Are Still Bullish On

February 04, 2025

Via MarketBeat

CMPX Stock Earnings: Compass Therapeutics Meets EPS for Q2 2024 ↗

August 12, 2024

Via InvestorPlace

12 Health Care Stocks Moving In Monday's After-Market Session ↗

June 10, 2024

Via Benzinga

CMPX Stock Earnings: Compass Therapeutics Beats EPS for Q1 2024 ↗

May 13, 2024

Via InvestorPlace

12 Health Care Stocks Moving In Wednesday's After-Market Session ↗

May 01, 2024

Via Benzinga

12 Health Care Stocks Moving In Friday's After-Market Session ↗

April 26, 2024

Via Benzinga

12 Health Care Stocks Moving In Thursday's Pre-Market Session ↗

April 25, 2024

Via Benzinga

3 Penny Stocks With the Power to 10X Your $1K Investment ↗

March 24, 2024

Via InvestorPlace

CMPX Stock Earnings: Compass Therapeutics Misses EPS for Q4 2023 ↗

March 21, 2024

Via InvestorPlace

12 Health Care Stocks Moving In Wednesday's Pre-Market Session ↗

March 13, 2024

Via Benzinga

12 Health Care Stocks Moving In Tuesday's After-Market Session ↗

March 05, 2024

Via Benzinga

12 Health Care Stocks Moving In Tuesday's After-Market Session ↗

February 27, 2024

Via Benzinga

12 Health Care Stocks Moving In Wednesday's After-Market Session ↗

January 17, 2024

Via Benzinga

3 Healthcare Stocks To Make You The Millionaire Next Door: October Edition ↗

October 13, 2023

Via InvestorPlace

Why NextGen Healthcare Shares Are Trading Higher By 13%; Here Are 20 Stocks Moving Premarket ↗

September 05, 2023

Via Benzinga

Frequently Asked Questions

Is Compass Therapeutics, Inc. - Common Stock publicly traded?

Yes, Compass Therapeutics, Inc. - Common Stock is publicly traded.

What exchange does Compass Therapeutics, Inc. - Common Stock trade on?

Compass Therapeutics, Inc. - Common Stock trades on the Nasdaq Stock Market

What is the ticker symbol for Compass Therapeutics, Inc. - Common Stock?

The ticker symbol for Compass Therapeutics, Inc. - Common Stock is CMPX on the Nasdaq Stock Market

What is the current price of Compass Therapeutics, Inc. - Common Stock?

The current price of Compass Therapeutics, Inc. - Common Stock is 5.360

When was Compass Therapeutics, Inc. - Common Stock last traded?

The last trade of Compass Therapeutics, Inc. - Common Stock was at 12/31/25 11:13 AM ET

What is the market capitalization of Compass Therapeutics, Inc. - Common Stock?

The market capitalization of Compass Therapeutics, Inc. - Common Stock is 683.33M

How many shares of Compass Therapeutics, Inc. - Common Stock are outstanding?

Compass Therapeutics, Inc. - Common Stock has 683M shares outstanding.

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.